A Guide for Clinicians in the Evaluation of Emerging Molecular Diagnostics for Newly Diagnosed Prostate Cancer

Prostate-specific antigen (PSA) screening is associated with a decline in prostate cancer-related mortality. However, screening has also led to overdiagnosis and overtreatment of clinically insignificant tumors. Recently, certain national guidelines (eg, US Preventive Services Task Force) have recom...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Rev Urol
Main Authors: Canfield, Steven E, Kibel, Adam S, Kemeter, Michael J, Febbo, Phillip G, Lawrence, H. Jeffrey, Moul, Judd W
Formato: Artigo
Idioma:Inglês
Publicado em: MedReviews, LLC 2014
Assuntos:
Diagnosis Update
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4274174/
https://ncbi.nlm.nih.gov/pubmed/25548544
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados